Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study
•Willingness to be vaccinated was generally high across the UK population.•Vaccine hesitancy exists in population subgroups.•Black and Pakistani/Bangladeshi ethnic groups had higher levels of vaccine hesitancy.•Vaccine hesitancy levels are higher in people with lower education levels.•Focus on ethni...
Saved in:
| Published in | Brain, behavior, and immunity Vol. 94; pp. 41 - 50 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Inc
01.05.2021
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | •Willingness to be vaccinated was generally high across the UK population.•Vaccine hesitancy exists in population subgroups.•Black and Pakistani/Bangladeshi ethnic groups had higher levels of vaccine hesitancy.•Vaccine hesitancy levels are higher in people with lower education levels.•Focus on ethnic minority and socioeconomic groups is needed during vaccine delivery.
Vaccine hesitancy could undermine efforts to control COVID-19. We investigated the prevalence of COVID-19 vaccine hesitancy in the UK and identified vaccine hesitant subgroups. The ‘Understanding Society’ COVID-19 survey asked participants (n = 12,035) their likelihood of vaccine uptake and reason for hesitancy. Cross-sectional analysis assessed vaccine hesitancy prevalence and logistic regression calculated odds ratios. Overall vaccine hesitancy was low (18% unlikely/very unlikely). Vaccine hesitancy was higher in women (21.0% vs 14.7%), younger age groups (26.5% in 16–24 year olds vs 4.5% in 75 + ) and those with lower education levels (18.6% no qualifications vs 13.2% degree qualified). Vaccine hesitancy was high in Black (71.8%) and Pakistani/Bangladeshi (42.3%) ethnic groups. Odds ratios for vaccine hesitancy were 13.42 (95% CI:6.86, 26.24) in Black and 2.54 (95% CI:1.19, 5.44) in Pakistani/Bangladeshi groups (compared to White British/Irish) and 3.54 (95% CI:2.06, 6.09) for people with no qualifications versus degree. Urgent action to address hesitancy is needed for some but not all ethnic minority groups. |
|---|---|
| AbstractList | Vaccine hesitancy could undermine efforts to control COVID-19. We investigated the prevalence of COVID-19 vaccine hesitancy in the UK and identified vaccine hesitant subgroups. The 'Understanding Society' COVID-19 survey asked participants (n = 12,035) their likelihood of vaccine uptake and reason for hesitancy. Cross-sectional analysis assessed vaccine hesitancy prevalence and logistic regression calculated odds ratios. Overall vaccine hesitancy was low (18% unlikely/very unlikely). Vaccine hesitancy was higher in women (21.0% vs 14.7%), younger age groups (26.5% in 16-24 year olds vs 4.5% in 75 + ) and those with lower education levels (18.6% no qualifications vs 13.2% degree qualified). Vaccine hesitancy was high in Black (71.8%) and Pakistani/Bangladeshi (42.3%) ethnic groups. Odds ratios for vaccine hesitancy were 13.42 (95% CI:6.86, 26.24) in Black and 2.54 (95% CI:1.19, 5.44) in Pakistani/Bangladeshi groups (compared to White British/Irish) and 3.54 (95% CI:2.06, 6.09) for people with no qualifications versus degree. Urgent action to address hesitancy is needed for some but not all ethnic minority groups. •Willingness to be vaccinated was generally high across the UK population.•Vaccine hesitancy exists in population subgroups.•Black and Pakistani/Bangladeshi ethnic groups had higher levels of vaccine hesitancy.•Vaccine hesitancy levels are higher in people with lower education levels.•Focus on ethnic minority and socioeconomic groups is needed during vaccine delivery. Vaccine hesitancy could undermine efforts to control COVID-19. We investigated the prevalence of COVID-19 vaccine hesitancy in the UK and identified vaccine hesitant subgroups. The ‘Understanding Society’ COVID-19 survey asked participants (n = 12,035) their likelihood of vaccine uptake and reason for hesitancy. Cross-sectional analysis assessed vaccine hesitancy prevalence and logistic regression calculated odds ratios. Overall vaccine hesitancy was low (18% unlikely/very unlikely). Vaccine hesitancy was higher in women (21.0% vs 14.7%), younger age groups (26.5% in 16–24 year olds vs 4.5% in 75 + ) and those with lower education levels (18.6% no qualifications vs 13.2% degree qualified). Vaccine hesitancy was high in Black (71.8%) and Pakistani/Bangladeshi (42.3%) ethnic groups. Odds ratios for vaccine hesitancy were 13.42 (95% CI:6.86, 26.24) in Black and 2.54 (95% CI:1.19, 5.44) in Pakistani/Bangladeshi groups (compared to White British/Irish) and 3.54 (95% CI:2.06, 6.09) for people with no qualifications versus degree. Urgent action to address hesitancy is needed for some but not all ethnic minority groups. • Willingness to be vaccinated was generally high across the UK population. • Vaccine hesitancy exists in population subgroups. • Black and Pakistani/Bangladeshi ethnic groups had higher levels of vaccine hesitancy. • Vaccine hesitancy levels are higher in people with lower education levels. • Focus on ethnic minority and socioeconomic groups is needed during vaccine delivery. Vaccine hesitancy could undermine efforts to control COVID-19. We investigated the prevalence of COVID-19 vaccine hesitancy in the UK and identified vaccine hesitant subgroups. The ‘Understanding Society’ COVID-19 survey asked participants (n = 12,035) their likelihood of vaccine uptake and reason for hesitancy. Cross-sectional analysis assessed vaccine hesitancy prevalence and logistic regression calculated odds ratios. Overall vaccine hesitancy was low (18% unlikely/very unlikely). Vaccine hesitancy was higher in women (21.0% vs 14.7%), younger age groups (26.5% in 16–24 year olds vs 4.5% in 75 + ) and those with lower education levels (18.6% no qualifications vs 13.2% degree qualified). Vaccine hesitancy was high in Black (71.8%) and Pakistani/Bangladeshi (42.3%) ethnic groups. Odds ratios for vaccine hesitancy were 13.42 (95% CI:6.86, 26.24) in Black and 2.54 (95% CI:1.19, 5.44) in Pakistani/Bangladeshi groups (compared to White British/Irish) and 3.54 (95% CI:2.06, 6.09) for people with no qualifications versus degree. Urgent action to address hesitancy is needed for some but not all ethnic minority groups. Vaccine hesitancy could undermine efforts to control COVID-19. We investigated the prevalence of COVID-19 vaccine hesitancy in the UK and identified vaccine hesitant subgroups. The 'Understanding Society' COVID-19 survey asked participants (n = 12,035) their likelihood of vaccine uptake and reason for hesitancy. Cross-sectional analysis assessed vaccine hesitancy prevalence and logistic regression calculated odds ratios. Overall vaccine hesitancy was low (18% unlikely/very unlikely). Vaccine hesitancy was higher in women (21.0% vs 14.7%), younger age groups (26.5% in 16-24 year olds vs 4.5% in 75 + ) and those with lower education levels (18.6% no qualifications vs 13.2% degree qualified). Vaccine hesitancy was high in Black (71.8%) and Pakistani/Bangladeshi (42.3%) ethnic groups. Odds ratios for vaccine hesitancy were 13.42 (95% CI:6.86, 26.24) in Black and 2.54 (95% CI:1.19, 5.44) in Pakistani/Bangladeshi groups (compared to White British/Irish) and 3.54 (95% CI:2.06, 6.09) for people with no qualifications versus degree. Urgent action to address hesitancy is needed for some but not all ethnic minority groups.Vaccine hesitancy could undermine efforts to control COVID-19. We investigated the prevalence of COVID-19 vaccine hesitancy in the UK and identified vaccine hesitant subgroups. The 'Understanding Society' COVID-19 survey asked participants (n = 12,035) their likelihood of vaccine uptake and reason for hesitancy. Cross-sectional analysis assessed vaccine hesitancy prevalence and logistic regression calculated odds ratios. Overall vaccine hesitancy was low (18% unlikely/very unlikely). Vaccine hesitancy was higher in women (21.0% vs 14.7%), younger age groups (26.5% in 16-24 year olds vs 4.5% in 75 + ) and those with lower education levels (18.6% no qualifications vs 13.2% degree qualified). Vaccine hesitancy was high in Black (71.8%) and Pakistani/Bangladeshi (42.3%) ethnic groups. Odds ratios for vaccine hesitancy were 13.42 (95% CI:6.86, 26.24) in Black and 2.54 (95% CI:1.19, 5.44) in Pakistani/Bangladeshi groups (compared to White British/Irish) and 3.54 (95% CI:2.06, 6.09) for people with no qualifications versus degree. Urgent action to address hesitancy is needed for some but not all ethnic minority groups. |
| Author | Moore, Jamie Green, Michael Katikireddi, Srinivasa Vittal Blake, Margaret Reeve, Kelly S. Benzeval, Michaela J. Niedzwiedz, Claire L. Robertson, Elaine |
| Author_xml | – sequence: 1 givenname: Elaine orcidid: 0000-0001-7481-5534 surname: Robertson fullname: Robertson, Elaine organization: MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, UK – sequence: 2 givenname: Kelly S. orcidid: 0000-0002-7485-950X surname: Reeve fullname: Reeve, Kelly S. organization: Understanding Society, Institute for Social and Economic Research, University of Essex, UK – sequence: 3 givenname: Claire L. surname: Niedzwiedz fullname: Niedzwiedz, Claire L. organization: Institute of Health & Wellbeing, College of Medical, Veterinary and Life Sciences, University of Glasgow, UK – sequence: 4 givenname: Jamie surname: Moore fullname: Moore, Jamie organization: Understanding Society, Institute for Social and Economic Research, University of Essex, UK – sequence: 5 givenname: Margaret surname: Blake fullname: Blake, Margaret organization: Ipsos MORI UK Ltd, UK – sequence: 6 givenname: Michael surname: Green fullname: Green, Michael organization: MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, UK – sequence: 7 givenname: Srinivasa Vittal surname: Katikireddi fullname: Katikireddi, Srinivasa Vittal email: Vittal.Katikireddi@glasgow.ac.uk organization: MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, UK – sequence: 8 givenname: Michaela J. surname: Benzeval fullname: Benzeval, Michaela J. organization: Understanding Society, Institute for Social and Economic Research, University of Essex, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33713824$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkc9rFDEcxYNU7Lb6B3iROXqZMZlMZhIEQVZti4X1YL2G_PhOJ2s2qcnswv73ZtlWtId6SiDv8x557wydhBgAodcENwST_t260do1LW5Jg2mDMX-GFgQLXLeEihO0wJyLmjBBTtFZzmuMMaOEv0CnlA6E8rZboNW3BNaZOaZcxbFarn5cfaqJqHbKGBegmiC7WQWzr1yo5gmqm6_VFLcZpuht5WO4dfPWuqB8lctl_xI9H5XP8Or-PEc3Xz5_X17W16uLq-XH69qwfphrrXoYNR6I4oxxJqC1FLfMgNaM2MH0io681722VhBgYuyV6AdGMFddazWn5-jD0fduqzdgDYQ5KS_vktuotJdROfnvS3CTvI07OYiuZx0pBm_vDVL8tYU8y43LBrxXAcr_ZMswaVkRd0X65u-sPyEPLRbBcBSYFHNOMEpTSptdPEQ7LwmWh73kWpa95GEviaksexWSPCIfzJ9i3h8ZKP3uHCSZjYNgyo4JzCxtdE_S4hFtvAvOKP8T9v9hfwND8sC5 |
| CitedBy_id | crossref_primary_10_1007_s40620_023_01586_z crossref_primary_10_1016_j_socscimed_2022_114819 crossref_primary_10_1186_s12879_023_08555_8 crossref_primary_10_3390_vaccines9090943 crossref_primary_10_1038_s41598_024_53825_3 crossref_primary_10_1111_hiv_70001 crossref_primary_10_3390_su14137623 crossref_primary_10_4103_jopcs_jopcs_1_23 crossref_primary_10_1097_MS9_0000000000000628 crossref_primary_10_1016_j_vaccine_2023_12_030 crossref_primary_10_3390_ijerph191811656 crossref_primary_10_1007_s10935_022_00702_2 crossref_primary_10_1177_17579139221094750 crossref_primary_10_1186_s12889_025_21988_x crossref_primary_10_1111_jan_15273 crossref_primary_10_1177_10901981231179503 crossref_primary_10_3390_systems9030060 crossref_primary_10_1111_jan_15398 crossref_primary_10_1007_s40273_021_01124_4 crossref_primary_10_1016_j_heliyon_2023_e16629 crossref_primary_10_1136_bmjopen_2023_073465 crossref_primary_10_21763_tjfmpc_1242149 crossref_primary_10_1016_j_ijdrr_2022_103181 crossref_primary_10_1016_j_vaccine_2023_11_016 crossref_primary_10_1016_j_healthpol_2022_08_001 crossref_primary_10_1016_j_euroecorev_2023_104463 crossref_primary_10_2147_IJGM_S314346 crossref_primary_10_1080_07853890_2023_2241351 crossref_primary_10_1080_00224499_2024_2382765 crossref_primary_10_1111_hex_13667 crossref_primary_10_1016_j_cegh_2024_101739 crossref_primary_10_7759_cureus_52480 crossref_primary_10_1007_s11673_024_10335_1 crossref_primary_10_1080_09515089_2023_2221929 crossref_primary_10_1177_10482911241273914 crossref_primary_10_3389_fpsyg_2023_1059676 crossref_primary_10_3390_ijerph182111702 crossref_primary_10_3390_vaccines10040559 crossref_primary_10_1016_j_puhe_2023_01_014 crossref_primary_10_3390_vaccines10040553 crossref_primary_10_1177_22799036221127627 crossref_primary_10_1016_j_puhe_2023_01_019 crossref_primary_10_3390_vaccines11050916 crossref_primary_10_1371_journal_pone_0301488 crossref_primary_10_3390_vaccines12010034 crossref_primary_10_1136_bmjopen_2021_048852 crossref_primary_10_3390_vaccines9090985 crossref_primary_10_1016_j_puhe_2024_04_012 crossref_primary_10_1093_ageing_afab229 crossref_primary_10_3389_fpubh_2021_794673 crossref_primary_10_1371_journal_pone_0301242 crossref_primary_10_1016_j_anai_2024_01_009 crossref_primary_10_1177_15327086211056575 crossref_primary_10_1016_j_jmh_2024_100217 crossref_primary_10_3390_vaccines10071081 crossref_primary_10_3390_vaccines11081301 crossref_primary_10_3390_vaccines10030425 crossref_primary_10_1177_13591053211017208 crossref_primary_10_25122_jml_2022_0086 crossref_primary_10_1186_s12884_021_04321_3 crossref_primary_10_3389_fpubh_2022_756037 crossref_primary_10_18231_j_jsas_2022_016 crossref_primary_10_1007_s10654_022_00905_1 crossref_primary_10_1038_s41598_022_17430_6 crossref_primary_10_1371_journal_pone_0296934 crossref_primary_10_29333_ejeph_14150 crossref_primary_10_3389_fpsyg_2022_876116 crossref_primary_10_3390_ijerph191912790 crossref_primary_10_3390_vaccines11020411 crossref_primary_10_3390_bs13110917 crossref_primary_10_1111_1471_0528_17508 crossref_primary_10_2174_18749445_v15_e2201200 crossref_primary_10_12688_f1000research_110545_1 crossref_primary_10_12688_f1000research_110545_2 crossref_primary_10_1016_j_pec_2022_03_023 crossref_primary_10_3390_healthcare11091207 crossref_primary_10_1186_s12982_024_00236_4 crossref_primary_10_1111_aphw_12457 crossref_primary_10_7748_cnp_2024_e1870 crossref_primary_10_29333_jconseph_12935 crossref_primary_10_1093_ooec_odad026 crossref_primary_10_1108_ER_09_2021_0409 crossref_primary_10_1136_bmjopen_2021_059844 crossref_primary_10_1186_s12889_021_12479_w crossref_primary_10_1111_ssqu_13106 crossref_primary_10_1016_j_epidem_2022_100581 crossref_primary_10_12688_f1000research_74575_6 crossref_primary_10_12688_f1000research_74575_5 crossref_primary_10_12688_f1000research_74575_2 crossref_primary_10_12688_f1000research_74575_4 crossref_primary_10_1007_s13278_023_01155_z crossref_primary_10_12688_f1000research_74575_3 crossref_primary_10_3389_fmed_2021_756275 crossref_primary_10_1080_21645515_2022_2031455 crossref_primary_10_1007_s40200_022_01018_y crossref_primary_10_3390_ijerph191610192 crossref_primary_10_2147_PPA_S334757 crossref_primary_10_3390_vaccines9080927 crossref_primary_10_1186_s12889_022_14587_7 crossref_primary_10_1371_journal_pone_0257237 crossref_primary_10_1093_heapro_daad088 crossref_primary_10_1177_18344909211039893 crossref_primary_10_3390_vaccines10040598 crossref_primary_10_1038_s41598_022_23035_w crossref_primary_10_1371_journal_pone_0261844 crossref_primary_10_1111_asap_12291 crossref_primary_10_1038_s41598_021_04765_9 crossref_primary_10_2139_ssrn_3989842 crossref_primary_10_2807_1560_7917_ES_2023_28_19_2200473 crossref_primary_10_1186_s12889_022_14261_y crossref_primary_10_7759_cureus_40626 crossref_primary_10_1002_jmv_27255 crossref_primary_10_3390_ijerph19127041 crossref_primary_10_1111_jir_12884 crossref_primary_10_1016_j_jmh_2022_100086 crossref_primary_10_1016_j_vaccine_2021_09_019 crossref_primary_10_1186_s12889_022_14972_2 crossref_primary_10_1007_s10935_022_00684_1 crossref_primary_10_1016_j_jvacx_2024_100584 crossref_primary_10_1016_j_vaccine_2023_02_030 crossref_primary_10_1186_s13031_022_00477_7 crossref_primary_10_3389_fpubh_2022_994125 crossref_primary_10_3390_vaccines10101748 crossref_primary_10_1186_s12889_024_18797_z crossref_primary_10_7554_eLife_78765 crossref_primary_10_3390_ijerph20042951 crossref_primary_10_1371_journal_pgph_0001435 crossref_primary_10_2196_32335 crossref_primary_10_1017_S0950268823001267 crossref_primary_10_3390_vaccines9080873 crossref_primary_10_3390_vaccines10101730 crossref_primary_10_3390_vaccines12070772 crossref_primary_10_4103_jfmpc_jfmpc_257_24 crossref_primary_10_1111_bjso_12537 crossref_primary_10_1371_journal_pgph_0000233 crossref_primary_10_54133_ajms_v5i_193 crossref_primary_10_1371_journal_pgph_0001204 crossref_primary_10_3390_ijerph19138033 crossref_primary_10_1038_s41562_022_01431_6 crossref_primary_10_3390_vaccines10081350 crossref_primary_10_1007_s40615_022_01372_w crossref_primary_10_1371_journal_pone_0297089 crossref_primary_10_1186_s12939_022_01685_6 crossref_primary_10_1007_s12144_022_03209_5 crossref_primary_10_17494_ogusbd_1041326 crossref_primary_10_1097_MS9_0000000000000921 crossref_primary_10_3390_bs13060501 crossref_primary_10_1136_bmjgh_2024_015200 crossref_primary_10_3346_jkms_2023_38_e234 crossref_primary_10_3389_fpsyt_2024_1402194 crossref_primary_10_1371_journal_pone_0276177 crossref_primary_10_3390_vaccines11081339 crossref_primary_10_1136_bmjopen_2022_065804 crossref_primary_10_1016_j_pmedr_2022_101812 crossref_primary_10_2217_fon_2022_0071 crossref_primary_10_1007_s10903_022_01402_z crossref_primary_10_1093_eurpub_ckad073 crossref_primary_10_1016_j_vaccine_2022_09_065 crossref_primary_10_1371_journal_pone_0269944 crossref_primary_10_1371_journal_pgph_0003529 crossref_primary_10_3390_vaccines10050780 crossref_primary_10_1016_j_vaccine_2022_01_038 crossref_primary_10_1016_j_socscimed_2023_115671 crossref_primary_10_3390_ijerph192215303 crossref_primary_10_3390_vaccines9070745 crossref_primary_10_1016_j_puhip_2022_100258 crossref_primary_10_3390_vaccines9101167 crossref_primary_10_1186_s13690_024_01306_4 crossref_primary_10_3390_vaccines11081381 crossref_primary_10_32481_djph_2021_022 crossref_primary_10_1016_j_vaccine_2024_04_076 crossref_primary_10_1371_journal_pgph_0000265 crossref_primary_10_3233_WOR_230092 crossref_primary_10_1038_s42005_022_00849_8 crossref_primary_10_3390_ijerph19116694 crossref_primary_10_1097_QAI_0000000000003243 crossref_primary_10_1002_jcop_22920 crossref_primary_10_1007_s10903_022_01337_5 crossref_primary_10_1016_j_vaccine_2023_03_053 crossref_primary_10_1007_s40609_023_00268_9 crossref_primary_10_1186_s12889_023_15386_4 crossref_primary_10_1016_j_vaccine_2023_01_023 crossref_primary_10_3390_healthcare9091165 crossref_primary_10_2989_16085906_2022_2118615 crossref_primary_10_1097_MD_0000000000033045 crossref_primary_10_1371_journal_pone_0264019 crossref_primary_10_3389_fpubh_2022_917242 crossref_primary_10_3390_vaccines9070759 crossref_primary_10_1016_j_vaccine_2023_02_059 crossref_primary_10_1093_jtm_taad084 crossref_primary_10_1080_21645515_2024_2448052 crossref_primary_10_1016_j_psychres_2021_114329 crossref_primary_10_2196_42143 crossref_primary_10_1016_j_vaccine_2024_03_027 crossref_primary_10_3390_vaccines10081270 crossref_primary_10_1177_00333549241250223 crossref_primary_10_1186_s13063_024_08054_4 crossref_primary_10_2196_29085 crossref_primary_10_1136_bmjopen_2024_092568 crossref_primary_10_1016_j_vaccine_2022_01_062 crossref_primary_10_3389_ijph_2023_1605547 crossref_primary_10_1016_j_socscimed_2023_115779 crossref_primary_10_1016_j_puhe_2023_04_007 crossref_primary_10_3389_fpubh_2023_1186429 crossref_primary_10_1007_s00520_021_06419_y crossref_primary_10_1002_14651858_MR000065_pub2 crossref_primary_10_1080_14760584_2022_2080057 crossref_primary_10_1186_s12889_022_14337_9 crossref_primary_10_7759_cureus_26337 crossref_primary_10_1007_s40615_024_01995_1 crossref_primary_10_1016_S0140_6736_21_00938_7 crossref_primary_10_3390_vaccines9101071 crossref_primary_10_3390_vaccines11030706 crossref_primary_10_1038_s41598_022_20340_2 crossref_primary_10_1080_21645515_2025_2475599 crossref_primary_10_1080_21645515_2022_2050121 crossref_primary_10_1136_bmjopen_2021_050062 crossref_primary_10_1016_j_ipm_2022_103013 crossref_primary_10_1371_journal_pone_0296049 crossref_primary_10_3390_vaccines11071259 crossref_primary_10_1038_s41433_021_01567_1 crossref_primary_10_3390_vaccines11071132 crossref_primary_10_1186_s12889_023_15334_2 crossref_primary_10_3390_ijerph192214655 crossref_primary_10_2139_ssrn_4178938 crossref_primary_10_3390_vaccines9101121 crossref_primary_10_2196_40587 crossref_primary_10_1016_j_jvacx_2023_100346 crossref_primary_10_1080_08870446_2023_2190761 crossref_primary_10_1080_13576275_2022_2044299 crossref_primary_10_1016_j_vaccine_2023_07_004 crossref_primary_10_1016_j_healthplace_2023_103098 crossref_primary_10_1371_journal_pgph_0001151 crossref_primary_10_3390_vaccines9111288 crossref_primary_10_3390_vaccines10091566 crossref_primary_10_3390_vaccines9070790 crossref_primary_10_1002_iid3_70076 crossref_primary_10_3390_vaccines10010106 crossref_primary_10_3390_vaccines10060840 crossref_primary_10_3390_vaccines9070794 crossref_primary_10_3390_ijerph192113723 crossref_primary_10_1186_s12889_023_15116_w crossref_primary_10_3390_vaccines10060968 crossref_primary_10_1128_jmbe_00051_23 crossref_primary_10_1038_s41562_023_01768_6 crossref_primary_10_1371_journal_pmed_1003932 crossref_primary_10_3390_ijerph181910438 crossref_primary_10_1136_bmj_n1138 crossref_primary_10_1136_bmjopen_2024_088418 crossref_primary_10_1111_imj_15731 crossref_primary_10_1136_jech_2020_216061 crossref_primary_10_1136_bmjph_2023_000658 crossref_primary_10_1177_01410768221095241 crossref_primary_10_12968_pnur_2021_32_10_420 crossref_primary_10_1371_journal_pmed_1003826 crossref_primary_10_1093_abm_kaae053 crossref_primary_10_1016_j_vaccine_2022_06_031 crossref_primary_10_1016_j_jiph_2023_03_003 crossref_primary_10_2807_1560_7917_ES_2022_27_33_2100885 crossref_primary_10_3390_pharmaceutics14051066 crossref_primary_10_1371_journal_pgph_0001053 crossref_primary_10_3390_vaccines10101595 crossref_primary_10_1016_j_jad_2024_08_066 crossref_primary_10_1038_s41598_023_33745_4 crossref_primary_10_7759_cureus_19282 crossref_primary_10_3390_vaccines9060628 crossref_primary_10_1111_tri_13979 crossref_primary_10_1016_j_puhe_2021_09_019 crossref_primary_10_1016_j_vaccine_2023_08_050 crossref_primary_10_3389_fpubh_2022_846861 crossref_primary_10_1038_s41591_021_01466_8 crossref_primary_10_1002_hec_4693 crossref_primary_10_1007_s10389_024_02325_9 crossref_primary_10_1111_risa_14200 crossref_primary_10_3389_fpubh_2022_854146 crossref_primary_10_1177_14034948221144661 crossref_primary_10_3389_fcomm_2021_707391 crossref_primary_10_3390_vaccines10050705 crossref_primary_10_1002_jcop_22652 crossref_primary_10_1177_00027642231166880 crossref_primary_10_1016_j_bbi_2021_03_021 crossref_primary_10_1371_journal_pone_0276519 crossref_primary_10_1016_j_socscimed_2022_114699 crossref_primary_10_1017_neu_2021_15 crossref_primary_10_4103_jehp_jehp_792_21 crossref_primary_10_1007_s13194_022_00480_y crossref_primary_10_1016_j_lanepe_2022_100317 crossref_primary_10_1016_j_puhe_2021_10_008 crossref_primary_10_1016_j_puhe_2022_10_006 crossref_primary_10_1080_14737167_2023_2223983 crossref_primary_10_5114_hpr_2021_111292 crossref_primary_10_1016_j_pedn_2024_03_017 crossref_primary_10_1177_20552076221145426 crossref_primary_10_1038_s41541_024_00951_8 crossref_primary_10_1108_HE_12_2021_0151 crossref_primary_10_1371_journal_pone_0287884 crossref_primary_10_1080_07359683_2022_2092325 crossref_primary_10_1093_heapro_daab209 crossref_primary_10_1093_ofid_ofac012 crossref_primary_10_1007_s10461_025_04622_0 crossref_primary_10_1371_journal_pone_0255702 crossref_primary_10_1016_j_vaccine_2024_126485 crossref_primary_10_1016_j_vaccine_2025_126781 crossref_primary_10_1080_13527266_2023_2289615 crossref_primary_10_1080_21645515_2023_2235964 crossref_primary_10_7759_cureus_46543 crossref_primary_10_1177_21676968221084876 crossref_primary_10_1016_j_jmh_2021_100050 crossref_primary_10_1007_s12144_023_04609_x crossref_primary_10_4103_jehp_jehp_940_21 crossref_primary_10_1371_journal_pone_0312799 crossref_primary_10_1016_j_jvacx_2023_100276 crossref_primary_10_1016_j_vaccine_2025_126997 crossref_primary_10_3390_vaccines10122101 crossref_primary_10_1093_postmj_qgae028 crossref_primary_10_1038_s43856_021_00027_x crossref_primary_10_1016_j_socscimed_2022_115403 crossref_primary_10_3390_vaccines9091010 crossref_primary_10_18332_popmed_154850 crossref_primary_10_17942_sted_1073402 crossref_primary_10_1007_s13679_021_00459_5 crossref_primary_10_1007_s10260_023_00709_x crossref_primary_10_12688_mep_19767_1 crossref_primary_10_1093_applin_amae083 crossref_primary_10_31067_acusaglik_1109356 crossref_primary_10_1016_j_vaccine_2021_09_010 crossref_primary_10_1089_hs_2021_0079 crossref_primary_10_1016_j_ssmph_2022_101150 crossref_primary_10_1016_j_vaccine_2022_06_007 crossref_primary_10_1016_j_vaccine_2022_08_070 crossref_primary_10_1016_S1473_3099_21_00404_7 crossref_primary_10_1186_s12879_022_07380_9 crossref_primary_10_1016_j_ajogmf_2022_100735 crossref_primary_10_2147_RMHP_S338520 crossref_primary_10_1080_10810730_2022_2148021 crossref_primary_10_1016_j_jinf_2024_01_008 crossref_primary_10_1093_geront_gnac036 crossref_primary_10_1007_s40615_022_01236_3 crossref_primary_10_1007_s40620_023_01690_0 crossref_primary_10_1377_hlthaff_2023_00775 crossref_primary_10_1016_S1473_3099_22_00119_0 crossref_primary_10_1038_s41586_022_05607_y crossref_primary_10_1186_s12889_024_18057_0 crossref_primary_10_2196_48466 crossref_primary_10_1016_j_ekir_2021_08_030 crossref_primary_10_1080_19371918_2022_2160855 crossref_primary_10_4997_jrcpe_2021_240 crossref_primary_10_3390_ijerph20010216 crossref_primary_10_3390_healthcare11010058 crossref_primary_10_2196_29942 crossref_primary_10_1055_s_0042_1747909 crossref_primary_10_1080_13669877_2021_2001674 crossref_primary_10_2139_ssrn_4099405 crossref_primary_10_2196_37466 crossref_primary_10_7759_cureus_17283 crossref_primary_10_1057_s41599_022_01034_6 crossref_primary_10_1016_j_jvacx_2022_100213 crossref_primary_10_2139_ssrn_3980243 crossref_primary_10_1080_07853890_2022_2027007 crossref_primary_10_3389_fpubh_2024_1380627 crossref_primary_10_1016_j_vaccine_2022_04_030 crossref_primary_10_1007_s10389_024_02199_x crossref_primary_10_1038_s41591_023_02665_1 crossref_primary_10_1016_j_heliyon_2022_e10728 crossref_primary_10_3390_vaccines11020288 crossref_primary_10_1155_2022_7299092 crossref_primary_10_3389_fcomm_2021_734996 crossref_primary_10_3390_ijerph182412903 crossref_primary_10_1080_21645515_2023_2256041 crossref_primary_10_1080_19325037_2024_2338083 crossref_primary_10_1093_heapro_daad034 crossref_primary_10_1016_j_bbih_2022_100447 crossref_primary_10_1080_14760584_2022_2021883 crossref_primary_10_1016_j_hsr_2021_100001 crossref_primary_10_3390_vaccines9111342 crossref_primary_10_1016_j_socscimed_2022_114981 crossref_primary_10_4103_crst_crst_138_21 crossref_primary_10_1136_bmjopen_2021_055278 crossref_primary_10_3389_fpubh_2022_971333 crossref_primary_10_1093_isr_viad017 crossref_primary_10_1371_journal_pgph_0000917 crossref_primary_10_1002_emp2_12830 crossref_primary_10_3389_fpsyg_2022_908917 crossref_primary_10_1186_s13104_024_06739_2 crossref_primary_10_3390_ijerph19063205 crossref_primary_10_3390_ijerph21101356 crossref_primary_10_3390_vaccines12090987 crossref_primary_10_1136_bmjph_2024_001240 crossref_primary_10_1177_14034948221100685 crossref_primary_10_1080_21645515_2021_1984123 crossref_primary_10_1016_j_vaccine_2025_126933 crossref_primary_10_1186_s12939_022_01723_3 crossref_primary_10_3390_ijerph191911971 crossref_primary_10_1177_00027642221146118 crossref_primary_10_3389_fpubh_2022_877668 crossref_primary_10_1186_s12879_022_07856_8 crossref_primary_10_3390_vaccines10030386 crossref_primary_10_4103_1995_7645_351769 crossref_primary_10_1080_17544750_2023_2232894 crossref_primary_10_1186_s12889_022_14090_z crossref_primary_10_1080_00131911_2021_2023102 crossref_primary_10_1016_j_vaccine_2022_04_003 crossref_primary_10_18231_j_jchm_2021_036 crossref_primary_10_1093_milmed_usac122 crossref_primary_10_5964_jspp_7425 crossref_primary_10_7759_cureus_63033 crossref_primary_10_1080_21645515_2022_2116206 crossref_primary_10_1186_s12889_023_17196_0 crossref_primary_10_1007_s12010_022_04181_3 crossref_primary_10_1111_tid_13749 crossref_primary_10_3390_vaccines11061086 crossref_primary_10_3390_vaccines9121449 crossref_primary_10_1016_j_econlet_2024_111768 crossref_primary_10_1038_s41598_022_16572_x crossref_primary_10_1177_23779608221141234 crossref_primary_10_1007_s40615_024_02172_0 crossref_primary_10_1080_10508422_2022_2059757 crossref_primary_10_1186_s12889_022_12823_8 crossref_primary_10_3389_fpubh_2022_882909 crossref_primary_10_1371_journal_pone_0309230 crossref_primary_10_4103_ijo_IJO_618_22 crossref_primary_10_1108_JSOCM_01_2024_0006 crossref_primary_10_3389_fpubh_2024_1382849 crossref_primary_10_1371_journal_pone_0300771 crossref_primary_10_1016_j_ypmed_2021_106885 crossref_primary_10_1080_21645515_2021_1985354 crossref_primary_10_1108_IJPHM_03_2022_0028 crossref_primary_10_3390_vaccines10091514 crossref_primary_10_1016_j_vaccine_2022_05_062 crossref_primary_10_1186_s12889_021_11071_6 crossref_primary_10_1016_j_vaccine_2023_07_070 crossref_primary_10_3390_vaccines12080839 crossref_primary_10_25259_SNI_690_2021 crossref_primary_10_3399_BJGP_2021_0376 crossref_primary_10_1136_bmjopen_2021_055085 crossref_primary_10_1016_j_vaccine_2021_11_090 crossref_primary_10_2147_IJWH_S396884 crossref_primary_10_7759_cureus_35961 crossref_primary_10_61474_ncs_2023_00009 crossref_primary_10_1097_CCE_0000000000000514 crossref_primary_10_2196_31707 crossref_primary_10_3389_fpsyt_2023_1272959 crossref_primary_10_1016_j_vaccine_2022_04_013 |
| Cites_doi | 10.1007/s10654-020-00671-y 10.1016/j.ypmed.2005.02.001 10.1080/21645515.2019.1695458 10.1016/j.ypmed.2015.12.018 10.1016/j.vaccine.2011.06.107 10.1016/j.socscimed.2020.113414 10.1177/1757913912453669 10.1186/s12916-020-01640-8 10.1016/S1473-3099(20)30426-6 10.1016/j.vaccine.2020.09.041 10.1001/jamanetworkopen.2020.25594 10.1080/14760584.2020.1825945 10.1038/s41467-020-20226-9 10.1038/s41586-020-2521-4 10.1007/s10654-020-00675-8 10.1016/j.immuni.2020.04.012 10.3390/vaccines8030482 10.1016/j.vaccine.2015.04.036 10.1016/j.bbi.2020.05.074 10.1136/jech-2020-214401 10.1016/j.vaccine.2020.10.059 10.1016/j.vaccine.2017.03.013 |
| ContentType | Journal Article |
| Copyright | 2021 The Author(s) Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. 2021 The Author(s) 2021 |
| Copyright_xml | – notice: 2021 The Author(s) – notice: Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. – notice: 2021 The Author(s) 2021 |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1016/j.bbi.2021.03.008 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1090-2139 |
| EndPage | 50 |
| ExternalDocumentID | PMC7946541 33713824 10_1016_j_bbi_2021_03_008 S0889159121001100 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United Kingdom |
| GeographicLocations_xml | – name: United Kingdom |
| GrantInformation_xml | – fundername: Chief Scientist Office grantid: SPHSU17 – fundername: Medical Research Council grantid: MC_PC_20030 – fundername: Chief Scientist Office grantid: SCAF/15/02 – fundername: Medical Research Council grantid: MC_PC_20059 – fundername: Medical Research Council grantid: MR/R024774/1 – fundername: Medical Research Council grantid: MC_UU_00022/2 |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM 9JO AAAJQ AADFP AAEDT AAEDW AAGJA AAGUQ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXLA AAXUO AAYWO ABCQJ ABFNM ABFRF ABIVO ABJNI ABMAC ABOYX ABWVN ABXDB ACDAQ ACGFO ACGFS ACRLP ACRPL ACVFH ACXNI ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CAG CJTIS COF CS3 DM4 DU5 EBS EFBJH EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMG HMQ HVGLF HZ~ IHE J1W KOM L7B LG5 LUGTX LZ5 M2U M41 MO0 MOBAO N9A O-L O9- OAUVE OH0 OKEIE OU- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SCC SDF SDG SDP SES SEW SIN SNS SPCBC SSB SSN SSY SSZ T5K TN5 UAP UNMZH UPT WUQ XPP XSW Z5R ZGI ZMT ~G- ~S- 6I. AACTN AADPK AAFTH AAIAV ABYKQ AFKWA AFYLN AJBFU AJOXV AMFUW EFLBG RIG SSI AAYXX AFCTW AGRNS BNPGV CITATION SSH CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c567t-ba6efb071a855859e2d3025cebb51d7c6a3f86b6bdd91e59f6a9675108a42db83 |
| IEDL.DBID | .~1 |
| ISSN | 0889-1591 1090-2139 |
| IngestDate | Thu Aug 21 18:17:29 EDT 2025 Fri Jul 11 08:20:27 EDT 2025 Mon Jul 21 05:35:59 EDT 2025 Thu Apr 24 23:12:45 EDT 2025 Tue Jul 01 04:10:32 EDT 2025 Fri Feb 23 02:45:40 EST 2024 Tue Aug 26 16:32:28 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | COVID-19 Ethnicity Vaccine uptake Vaccine hesitancy Socioeconomic position Inequalities |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c567t-ba6efb071a855859e2d3025cebb51d7c6a3f86b6bdd91e59f6a9675108a42db83 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 equal contribution |
| ORCID | 0000-0001-7481-5534 0000-0002-7485-950X |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0889159121001100 |
| PMID | 33713824 |
| PQID | 2501259464 |
| PQPubID | 23479 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7946541 proquest_miscellaneous_2501259464 pubmed_primary_33713824 crossref_citationtrail_10_1016_j_bbi_2021_03_008 crossref_primary_10_1016_j_bbi_2021_03_008 elsevier_sciencedirect_doi_10_1016_j_bbi_2021_03_008 elsevier_clinicalkey_doi_10_1016_j_bbi_2021_03_008 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | May 2021 2021-05-00 20210501 |
| PublicationDateYYYYMMDD | 2021-05-01 |
| PublicationDate_xml | – month: 05 year: 2021 text: May 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Brain, behavior, and immunity |
| PublicationTitleAlternate | Brain Behav Immun |
| PublicationYear | 2021 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Benzeval M, Burton J, Crossley TF, Fisher P, Gardiner C, Jӓckle A, et al. High frequency online data collection in an annual household panel study: some evidence on bias prevention and bias adjustment. Understanding Society Working Paper Series No 2021 – 03. Colchester: ISER University of Essex; 2021. R Core Team (b0135) 2018 Institute for Social and Economic Research (b0045) 2020 Paul, Steptoe, Fancourt (b0125) 2021 Randolph, Barreiro (b0140) 2020; 52 Institute for Social and Economic Research. Understanding Society COVID-19 User Guide. Version 5.0, November 20Colchester: University of Essex; 2020. Ward JK, Alleaume C, Peretti-Watel P, Group C, 1982, The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue. Social Science & Medicine. 2020; 265:113414. WHO. WHO Coronavirus Disease (COVID-19) Dashboard: World Health Organisation; 2020 Available from: https://covid19.who.int/. Accessed 18/12/2020. Shen (b0155) 2020; 16 Verger, Dube (b0165) 2020 Bambra, Riordan, Ford, Matthews (b0005) 2020; 74 Han, Michie, Potts, Rubin (b0040) 2016; 84 Robinson, Jones, Lesser, Daly (b0145) 2020; 2020 Ethnicity subgroup of the Scientific Advisory Group on Emergencies. Drivers of the higher COVID-19 incidence, morbidity and mortality among minority ethnic groups, 23 September 2020. UK Government Office of Science; 2020. Jain, van Hoek, Boccia, Thomas (b0065) 2017; 35 Lumley T. Package ‘survey’ - Analysis of Complex Survey Samples: CRAN; 2020 [Available from: https://cran.r-project.org/web/packages/survey/survey.pdf. Grech, Gauci, Agius (b0035) 2020 Kreps, Prasad, Brownstein, Hswen, Garibaldi, Zhang (b0080) 2020; 3 Wang, Jing, Lai, Zhang, Lyu, Knoll (b0170) 2020; 8 Peretti-Watel, Seror, Cortaredona, Launay, Raude, Verger (b0130) 2020; 20 Institute for Social and Economic Research. Understanding Society: Waves 1-9, 2009-2018 and Harmonised BHPS: Waves 1-18, 1991-2009, User Guide. Colchester: University of Essex; 2020 12 August 2020. Mills, Rahal, Brazel, Yan, Gieysztor (b0105) 2020 Williamson, Walker, Bhaskaran, Bacon, Bates, Morton (b0200) 2020; 584 Mangtani, Breeze, Kovats, Ng, Roberts, Fletcher (b0100) 2005; 41 Detoc, Bruel, Frappe, Tardy, Botelho-Nevers, Gagneux-Brunon (b0020) 2020; 38 Williams, Flowers, McLeod, Young, Rollins (b0195) 2021; 9 Murphy, Vallières, Bentall, Shevlin, McBride, Hartman (b0110) 2021; 12 WHO. Vaccines and immunization: World Health Organisation; 2020 [Available from: https://www.who.int/health-topics/vaccines-and-immunization. Niedzwiedz, O’Donnell, Jani, Demou, Ho, Celis-Morales (b0115) 2020; 18 MacDonald (b0095) 2015; 33 WHO. Ten Threats to Global Health in 2019: World Health Organisation; 2019 Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019. Woodall, White, South (b0205) 2013; 133 Yeung, Lam, Coker (b0210) 2016; 38 Lassale, Gaye, Hamer, Gale, Batty (b0085) 2020; 88 Bish, Yardley, Nicoll, Michie (b0015) 2020; 29 Ipsos. Global attitudes on a covid-19 vaccine. Online; 2020 17 December 2020. Freeman, Loe, Chadwick, Vaccari, Waite, Rosebrock (b0030) 2020; 1 University of Essex, Institute for Social Economic Research. Understanding Society: COVID-19 Study. UK Data Service. SN: 8644, 10.5255/UKDA‐SN‐8644‐4; 2020. Accessed: 23/9/2020. Joint Committee on Vaccination and Immunisation. Advice on priority groups for COVID-19 vaccination: UK Government; 2020 [Available from: https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-2-december-2020. Palamenghi, Barello, Boccia, Graffigna (b0120) 2020; 35 Schoch-Spana M, Brunson EK, Long R, Ruth A, Ravi SJ, Trotochaud M, et al. 2020. The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States. Vaccine. Dror, Eisenbach, Taiber, Morozov, Mizrachi, Zigron (b0025) 2020; 35 Kreps (10.1016/j.bbi.2021.03.008_b0080) 2020; 3 10.1016/j.bbi.2021.03.008_b0090 10.1016/j.bbi.2021.03.008_b0190 Detoc (10.1016/j.bbi.2021.03.008_b0020) 2020; 38 10.1016/j.bbi.2021.03.008_b0070 Peretti-Watel (10.1016/j.bbi.2021.03.008_b0130) 2020; 20 R Core Team (10.1016/j.bbi.2021.03.008_b0135) 2018 10.1016/j.bbi.2021.03.008_b0050 10.1016/j.bbi.2021.03.008_b0150 10.1016/j.bbi.2021.03.008_b0075 Williamson (10.1016/j.bbi.2021.03.008_b0200) 2020; 584 10.1016/j.bbi.2021.03.008_b0010 Han (10.1016/j.bbi.2021.03.008_b0040) 2016; 84 Randolph (10.1016/j.bbi.2021.03.008_b0140) 2020; 52 10.1016/j.bbi.2021.03.008_b0175 10.1016/j.bbi.2021.03.008_b0055 Lassale (10.1016/j.bbi.2021.03.008_b0085) 2020; 88 Murphy (10.1016/j.bbi.2021.03.008_b0110) 2021; 12 Shen (10.1016/j.bbi.2021.03.008_b0155) 2020; 16 Jain (10.1016/j.bbi.2021.03.008_b0065) 2017; 35 Palamenghi (10.1016/j.bbi.2021.03.008_b0120) 2020; 35 Wang (10.1016/j.bbi.2021.03.008_b0170) 2020; 8 Dror (10.1016/j.bbi.2021.03.008_b0025) 2020; 35 Yeung (10.1016/j.bbi.2021.03.008_b0210) 2016; 38 Mills (10.1016/j.bbi.2021.03.008_b0105) 2020 10.1016/j.bbi.2021.03.008_b0180 10.1016/j.bbi.2021.03.008_b0060 Freeman (10.1016/j.bbi.2021.03.008_b0030) 2020; 1 10.1016/j.bbi.2021.03.008_b0160 Bambra (10.1016/j.bbi.2021.03.008_b0005) 2020; 74 Niedzwiedz (10.1016/j.bbi.2021.03.008_b0115) 2020; 18 Paul (10.1016/j.bbi.2021.03.008_b0125) 2021 10.1016/j.bbi.2021.03.008_b0185 Mangtani (10.1016/j.bbi.2021.03.008_b0100) 2005; 41 Grech (10.1016/j.bbi.2021.03.008_b0035) 2020 Verger (10.1016/j.bbi.2021.03.008_b0165) 2020 Institute for Social and Economic Research (10.1016/j.bbi.2021.03.008_b0045) 2020 Williams (10.1016/j.bbi.2021.03.008_b0195) 2021; 9 Bish (10.1016/j.bbi.2021.03.008_b0015) 2020; 29 Robinson (10.1016/j.bbi.2021.03.008_b0145) 2020; 2020 Woodall (10.1016/j.bbi.2021.03.008_b0205) 2013; 133 MacDonald (10.1016/j.bbi.2021.03.008_b0095) 2015; 33 |
| References_xml | – volume: 8 start-page: 482 year: 2020 ident: b0170 article-title: Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China publication-title: Vaccines. – volume: 584 start-page: 430 year: 2020 end-page: 436 ident: b0200 article-title: Factors associated with COVID-19-related death using OpenSAFELY publication-title: Nature – reference: Institute for Social and Economic Research. Understanding Society: Waves 1-9, 2009-2018 and Harmonised BHPS: Waves 1-18, 1991-2009, User Guide. Colchester: University of Essex; 2020 12 August 2020. – reference: Lumley T. Package ‘survey’ - Analysis of Complex Survey Samples: CRAN; 2020 [Available from: https://cran.r-project.org/web/packages/survey/survey.pdf. – reference: Ward JK, Alleaume C, Peretti-Watel P, Group C, 1982, The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue. Social Science & Medicine. 2020; 265:113414. – reference: Joint Committee on Vaccination and Immunisation. Advice on priority groups for COVID-19 vaccination: UK Government; 2020 [Available from: https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-2-december-2020. – volume: 88 start-page: 44 year: 2020 end-page: 49 ident: b0085 article-title: Ethnic disparities in hospitalisation for COVID-19 in England: The role of socioeconomic factors, mental health, and inflammatory and pro-inflammatory factors in a community-based cohort study publication-title: Brain Behav Immun. – reference: Accessed: 23/9/2020. – year: 2020 ident: b0035 article-title: Vaccine hesitancy among Maltese healthcare workers toward influenza and novel COVID-19 vaccination publication-title: Early Hum Dev. – reference: WHO. WHO Coronavirus Disease (COVID-19) Dashboard: World Health Organisation; 2020 Available from: https://covid19.who.int/. Accessed 18/12/2020. – year: 2018 ident: b0135 article-title: R: A language and environment for statistical computing – year: 2020 ident: b0105 article-title: COVID-19 vaccine deployment: Behaviour, ethics, misinformation and policy strategies – volume: 12 start-page: 29 year: 2021 ident: b0110 article-title: Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom publication-title: Nat. Commun. – volume: 1 year: 2020 ident: b0030 article-title: COVID-19 vaccine hesitancy in the UK: The oxford coronavirus explanations, attitudes, and narratives survey (OCEANS) II publication-title: Psychol Med. – year: 2020 ident: b0045 article-title: Understanding society: Waves 1–10, 2009–2019 and harmonised BHPS: Waves 1–18, 1991–2009, user guide – volume: 38 start-page: 746 year: 2016 end-page: 753 ident: b0210 article-title: Factors associated with the uptake of seasonal influenza vaccination in adults: a systematic review publication-title: J. Public Health. – volume: 74 start-page: 964 year: 2020 ident: b0005 article-title: The COVID-19 pandemic and health inequalities publication-title: J. Epidemiol Community Health. – volume: 52 start-page: 737 year: 2020 end-page: 741 ident: b0140 article-title: Herd immunity: Understanding COVID-19 publication-title: Immunity – volume: 16 start-page: 1030 year: 2020 end-page: 1033 ident: b0155 article-title: Finding a way to address a wicked problem: vaccines, vaccination, and a shared understanding publication-title: Hum Vaccin Immunother. – year: 2020 ident: b0165 article-title: Restoring confidence in vaccines in the COVID-19 era publication-title: Expert Rev. Vaccines. – reference: WHO. Ten Threats to Global Health in 2019: World Health Organisation; 2019 Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019. – reference: Benzeval M, Burton J, Crossley TF, Fisher P, Gardiner C, Jӓckle A, et al. High frequency online data collection in an annual household panel study: some evidence on bias prevention and bias adjustment. Understanding Society Working Paper Series No 2021 – 03. Colchester: ISER University of Essex; 2021. – volume: 38 start-page: 7002 year: 2020 end-page: 7006 ident: b0020 article-title: Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic publication-title: Vaccine. – reference: Schoch-Spana M, Brunson EK, Long R, Ruth A, Ravi SJ, Trotochaud M, et al. 2020. The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States. Vaccine. – reference: Ethnicity subgroup of the Scientific Advisory Group on Emergencies. Drivers of the higher COVID-19 incidence, morbidity and mortality among minority ethnic groups, 23 September 2020. UK Government Office of Science; 2020. – reference: University of Essex, Institute for Social Economic Research. Understanding Society: COVID-19 Study. UK Data Service. SN: 8644, 10.5255/UKDA‐SN‐8644‐4; 2020. – volume: 35 start-page: 785 year: 2020 end-page: 788 ident: b0120 article-title: Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy publication-title: Eur J Epidemiol. – volume: 18 start-page: 160 year: 2020 ident: b0115 article-title: Ethnic and socioeconomic differences in SARS-CoV-2 infection: Prospective cohort study using UK Biobank publication-title: BMC Med. – reference: WHO. Vaccines and immunization: World Health Organisation; 2020 [Available from: https://www.who.int/health-topics/vaccines-and-immunization. – volume: 33 start-page: 4161 year: 2015 end-page: 4164 ident: b0095 article-title: Vaccine hesitancy: Definition, scope and determinants publication-title: Vaccine. – volume: 9 year: 2021 ident: b0195 article-title: The catalyst project T. social patterning and stability of intention to accept a COVID-19 vaccine in Scotland: Will those most at risk accept a vaccine? publication-title: Vaccines (Basel) – reference: Institute for Social and Economic Research. Understanding Society COVID-19 User Guide. Version 5.0, November 20Colchester: University of Essex; 2020. – volume: 3 year: 2020 ident: b0080 article-title: Factors associated with US adults' likelihood of accepting COVID-19 vaccination publication-title: JAMA Network Open. – volume: 2020 year: 2020 ident: b0145 article-title: International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples publication-title: medRxiv. – volume: 35 start-page: 2315 year: 2017 end-page: 2328 ident: b0065 article-title: Lower vaccine uptake amongst older individuals living alone: A systematic review and meta-analysis of social determinants of vaccine uptake publication-title: Vaccine. – reference: Ipsos. Global attitudes on a covid-19 vaccine. Online; 2020 17 December 2020. – volume: 35 start-page: 775 year: 2020 end-page: 779 ident: b0025 article-title: Vaccine hesitancy: The next challenge in the fight against COVID-19 publication-title: Eur J Epidemiol. – volume: 20 start-page: 769 year: 2020 end-page: 770 ident: b0130 article-title: A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation publication-title: Lancet. Infect. Dis – volume: 84 start-page: 57 year: 2016 end-page: 61 ident: b0040 article-title: Predictors of influenza vaccine uptake during the 2009/10 influenza A H1N1v (‘swine flu’) pandemic: Results from five national surveys in the United Kingdom publication-title: Prev Med (Baltim) – volume: 41 start-page: 545 year: 2005 end-page: 553 ident: b0100 article-title: Inequalities in influenza vaccine uptake among people aged over 74 years in Britain publication-title: Prev Med. – year: 2021 ident: b0125 article-title: Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. publication-title: Europe. – volume: 29 start-page: 6472 year: 2020 end-page: 6484 ident: b0015 article-title: Factors associated with uptake of vaccination against pandemic influenza: A systematic review publication-title: Vaccine. – volume: 133 start-page: 96 year: 2013 end-page: 103 ident: b0205 article-title: Improving health and well-being through community health champions: a thematic evaluation of a programme in Yorkshire and Humber publication-title: Perspect Public Health. – ident: 10.1016/j.bbi.2021.03.008_b0090 – year: 2018 ident: 10.1016/j.bbi.2021.03.008_b0135 – volume: 1 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0030 article-title: COVID-19 vaccine hesitancy in the UK: The oxford coronavirus explanations, attitudes, and narratives survey (OCEANS) II publication-title: Psychol Med. – ident: 10.1016/j.bbi.2021.03.008_b0180 – volume: 35 start-page: 775 issue: 8 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0025 article-title: Vaccine hesitancy: The next challenge in the fight against COVID-19 publication-title: Eur J Epidemiol. doi: 10.1007/s10654-020-00671-y – ident: 10.1016/j.bbi.2021.03.008_b0160 – ident: 10.1016/j.bbi.2021.03.008_b0055 – volume: 41 start-page: 545 issue: 2 year: 2005 ident: 10.1016/j.bbi.2021.03.008_b0100 article-title: Inequalities in influenza vaccine uptake among people aged over 74 years in Britain publication-title: Prev Med. doi: 10.1016/j.ypmed.2005.02.001 – volume: 16 start-page: 1030 issue: 5 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0155 article-title: Finding a way to address a wicked problem: vaccines, vaccination, and a shared understanding publication-title: Hum Vaccin Immunother. doi: 10.1080/21645515.2019.1695458 – year: 2021 ident: 10.1016/j.bbi.2021.03.008_b0125 article-title: Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. The Lancet Regional Health - publication-title: Europe. – volume: 9 issue: 1 year: 2021 ident: 10.1016/j.bbi.2021.03.008_b0195 article-title: The catalyst project T. social patterning and stability of intention to accept a COVID-19 vaccine in Scotland: Will those most at risk accept a vaccine? publication-title: Vaccines (Basel) – ident: 10.1016/j.bbi.2021.03.008_b0185 – year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0035 article-title: Vaccine hesitancy among Maltese healthcare workers toward influenza and novel COVID-19 vaccination publication-title: Early Hum Dev. – volume: 84 start-page: 57 year: 2016 ident: 10.1016/j.bbi.2021.03.008_b0040 article-title: Predictors of influenza vaccine uptake during the 2009/10 influenza A H1N1v (‘swine flu’) pandemic: Results from five national surveys in the United Kingdom publication-title: Prev Med (Baltim) doi: 10.1016/j.ypmed.2015.12.018 – ident: 10.1016/j.bbi.2021.03.008_b0190 – volume: 29 start-page: 6472 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0015 article-title: Factors associated with uptake of vaccination against pandemic influenza: A systematic review publication-title: Vaccine. doi: 10.1016/j.vaccine.2011.06.107 – ident: 10.1016/j.bbi.2021.03.008_b0175 doi: 10.1016/j.socscimed.2020.113414 – volume: 133 start-page: 96 issue: 2 year: 2013 ident: 10.1016/j.bbi.2021.03.008_b0205 article-title: Improving health and well-being through community health champions: a thematic evaluation of a programme in Yorkshire and Humber publication-title: Perspect Public Health. doi: 10.1177/1757913912453669 – volume: 18 start-page: 160 issue: 1 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0115 article-title: Ethnic and socioeconomic differences in SARS-CoV-2 infection: Prospective cohort study using UK Biobank publication-title: BMC Med. doi: 10.1186/s12916-020-01640-8 – volume: 20 start-page: 769 issue: 7 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0130 article-title: A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation publication-title: Lancet. Infect. Dis doi: 10.1016/S1473-3099(20)30426-6 – volume: 38 start-page: 7002 issue: 45 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0020 article-title: Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic publication-title: Vaccine. doi: 10.1016/j.vaccine.2020.09.041 – ident: 10.1016/j.bbi.2021.03.008_b0060 – year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0105 – ident: 10.1016/j.bbi.2021.03.008_b0070 – ident: 10.1016/j.bbi.2021.03.008_b0010 – volume: 3 issue: 10 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0080 article-title: Factors associated with US adults' likelihood of accepting COVID-19 vaccination publication-title: JAMA Network Open. doi: 10.1001/jamanetworkopen.2020.25594 – year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0165 article-title: Restoring confidence in vaccines in the COVID-19 era publication-title: Expert Rev. Vaccines. doi: 10.1080/14760584.2020.1825945 – year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0045 – volume: 12 start-page: 29 issue: 1 year: 2021 ident: 10.1016/j.bbi.2021.03.008_b0110 article-title: Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom publication-title: Nat. Commun. doi: 10.1038/s41467-020-20226-9 – volume: 584 start-page: 430 issue: 7821 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0200 article-title: Factors associated with COVID-19-related death using OpenSAFELY publication-title: Nature doi: 10.1038/s41586-020-2521-4 – volume: 2020 issue: 12 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0145 article-title: International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples publication-title: medRxiv. – volume: 35 start-page: 785 issue: 8 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0120 article-title: Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy publication-title: Eur J Epidemiol. doi: 10.1007/s10654-020-00675-8 – volume: 52 start-page: 737 issue: 5 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0140 article-title: Herd immunity: Understanding COVID-19 publication-title: Immunity doi: 10.1016/j.immuni.2020.04.012 – volume: 8 start-page: 482 issue: 3 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0170 article-title: Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China publication-title: Vaccines. doi: 10.3390/vaccines8030482 – volume: 33 start-page: 4161 issue: 34 year: 2015 ident: 10.1016/j.bbi.2021.03.008_b0095 article-title: Vaccine hesitancy: Definition, scope and determinants publication-title: Vaccine. doi: 10.1016/j.vaccine.2015.04.036 – ident: 10.1016/j.bbi.2021.03.008_b0075 – volume: 88 start-page: 44 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0085 article-title: Ethnic disparities in hospitalisation for COVID-19 in England: The role of socioeconomic factors, mental health, and inflammatory and pro-inflammatory factors in a community-based cohort study publication-title: Brain Behav Immun. doi: 10.1016/j.bbi.2020.05.074 – ident: 10.1016/j.bbi.2021.03.008_b0050 – volume: 74 start-page: 964 issue: 11 year: 2020 ident: 10.1016/j.bbi.2021.03.008_b0005 article-title: The COVID-19 pandemic and health inequalities publication-title: J. Epidemiol Community Health. doi: 10.1136/jech-2020-214401 – ident: 10.1016/j.bbi.2021.03.008_b0150 doi: 10.1016/j.vaccine.2020.10.059 – volume: 35 start-page: 2315 issue: 18 year: 2017 ident: 10.1016/j.bbi.2021.03.008_b0065 article-title: Lower vaccine uptake amongst older individuals living alone: A systematic review and meta-analysis of social determinants of vaccine uptake publication-title: Vaccine. doi: 10.1016/j.vaccine.2017.03.013 – volume: 38 start-page: 746 issue: 4 year: 2016 ident: 10.1016/j.bbi.2021.03.008_b0210 article-title: Factors associated with the uptake of seasonal influenza vaccination in adults: a systematic review publication-title: J. Public Health. |
| SSID | ssj0005318 |
| Score | 2.7092695 |
| Snippet | •Willingness to be vaccinated was generally high across the UK population.•Vaccine hesitancy exists in population subgroups.•Black and Pakistani/Bangladeshi... Vaccine hesitancy could undermine efforts to control COVID-19. We investigated the prevalence of COVID-19 vaccine hesitancy in the UK and identified vaccine... • Willingness to be vaccinated was generally high across the UK population. • Vaccine hesitancy exists in population subgroups. • Black and... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 41 |
| SubjectTerms | COVID-19 COVID-19 Vaccines Cross-Sectional Studies Ethnicity Female Humans Inequalities Longitudinal Studies Minority Groups SARS-CoV-2 Socioeconomic position United Kingdom Vaccine hesitancy Vaccine uptake Vaccines |
| Title | Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0889159121001100 https://dx.doi.org/10.1016/j.bbi.2021.03.008 https://www.ncbi.nlm.nih.gov/pubmed/33713824 https://www.proquest.com/docview/2501259464 https://pubmed.ncbi.nlm.nih.gov/PMC7946541 |
| Volume | 94 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED5KC2UvY2v3I91WVBh7GHixLVmyHkPWkq4_6ZbRN2HZMnFpndIlg77sb9-dbIemZR30KY4tgdCd7z5Zn74D-ChUorKUF4HNyjAQ0oVB6ugqlLnTChOSprPDR8dyNBbfzpPzFRh2Z2GIVtnG_iam-2jd3um3s9m_rqr-dyLoYDImBSwvfEYn2IUiL__y5w7No_nG59k81Lrb2fQcL2srXCLGUatz-q_c9BB73qdQ3slJey_geQsm2aAZ70tYcfUGbA5qXEhf3bJPzNM7_XfzDVg_anfRN-Hk9Iauqc4Om5ZsePJz_2sQafY7y6kBm1CtAIq6rKoZAkQ2PmCT6fyXo60qdjmlEkfzgsppMa9O-wrGe7s_hqOgLawQ5IlUM7SLdKVFcJGlCS4XtIsLjtgnd9YmUaFymfEylVbaotCRS3QpM40LiyhMMxEXNuWvYbWe1u4tsLQodWStxTAQk1INxqycSxkqxxHKxLwHYTelJm9Vx6n4xaXp6GUXBq1gyAom5Aat0IPPiy7XjeTGY43jzk6mO0uK0c9gQnisk1h0WnK2_3Xb6RzB4EtIOytZ7XD6DeJIBIpaSNGDN41jLIbOuSKdR3yillxm0YAEvpef1NXEC32T-H8ioq2nDfcdPKN_DTvzPazObubuAyKomd32r8g2rA2GZ4en9Lt_MDr-C7HhGjA |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED5BkWAvaIP9KPtlJLQHpKhJnDjxY9UNtSstSKOINytOHDVTSRG0SPz3u0ucjm4ak3iLYp9k-Zy7z_Hn7wCOgiiMkphnjk5y1wmEcZ3Y0JMrUiMjTEiS7g6PxqI_Cb5fhVcb0GvuwhCt0sb-OqZX0dq-6djZ7NwURecHEXQwGZMCViV8tglbpE4VtmCrOxj2x7-ZHvVvvorQQwbN4WZF89K6wF2i71mp03-lp7_h558sykdp6eQl7Fo8ybr1kF_Bhin3YL9b4l76-oF9YRXDs_p1vgfbI3uQvg9n57f0TKV22DxnvbPLwVfHk-w-SakDm1K5AAq8rCgZYkQ2GbLpfHln6LSKzeZU5WiZUUUtVgnUvobJybeLXt-xtRWcNBTRAl0jTK4RXyRxiDsGafyMI_xJjdahl0WpSHgeCy10lknPhDIXicS9hefGSeBnOuZvoFXOS_MOWJzl0tNaYyTwSawGw1bKhXAjwxHN-LwNbjOlKrXC41T_YqYahtlPhV5Q5AXlcoVeaMPxyuSmVt14qrPf-Ek110kxACrMCU8ZBSujtfX2P7PDZiEo_A7pcCUpDU6_QiiJWFEGImjD23phrIbOeURSj9gSrS2ZVQfS-F5vKYtppfVN-v9h4B08b7ifYad_MTpVp4Px8D28oJaarPkBWovbpfmIgGqhP9kP5hd46htM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictors+of+COVID-19+vaccine+hesitancy+in+the+UK+household+longitudinal+study&rft.jtitle=Brain%2C+behavior%2C+and+immunity&rft.au=Robertson%2C+Elaine&rft.au=Reeve%2C+Kelly+S&rft.au=Niedzwiedz%2C+Claire+L&rft.au=Moore%2C+Jamie&rft.date=2021-05-01&rft.issn=1090-2139&rft.eissn=1090-2139&rft.volume=94&rft.spage=41&rft_id=info:doi/10.1016%2Fj.bbi.2021.03.008&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0889-1591&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0889-1591&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0889-1591&client=summon |